Lallemand Health Solutions

IBacilluS +

Highly stable 2-strain probiotic

More than 140 clinical studies

A specific probiotic formula combining:

Bacillus subtilis Rosell^®-179
Enterococcus faecium Rosell^®-26

15 Clinical studies and meta-analysis (Chen 2012) show a positive effect on IBS-like symptoms

Self-affirmed GRAS on Bacillus subtilis Rosell^®-179

For other use than food/dietary supplements, other clinical studies show:

Prevention and treatment of AAD in infant, children, and adults (Liu 2012)
A lower recurrence rate of UC in combination with conventional treatment (Hu 2013)

© 2024 Lallemand Inc. All right reserved.
The information contained herein is business-to-business information and is not intended for the final consumer. It is based on our research and development work and is, to the best of our knowledge, reliable. Lallemand Health Solutions does not assume any liability resulting from the use of its products, as conditions of use are beyond our control. The business-to-business information provided should not be used as a substitute for any form of advice. In all instances, producers and marketers should check local regulatory requirements before use as different claims may be made depending on the regulations applicable in each country.